Circulating Tumor DNA-Guided Adjuvant Therapy in Locally Advanced Colon Cancer: The Randomized Phase II/III DYNAMIC-III Trial

In this multicenter, randomized, Phase II/III trial, patients with stage III colon cancer underwent ctDNA testing five–six weeks after surgery and were assigned to ctDNA-guided or standard management.